| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | NovoCure Ltd | 9,759,087 | 9.1% | EDGAR |
| SC 13G/A | 2024-02-09 | FMR LLC | NovoCure Ltd | 15,962,765 | 14.9% | EDGAR |
| SC 13G/A | 2024-02-09 | BlackRock Inc. | NovoCure Ltd | 8,792,035 | 8.2% | EDGAR |
| SC 13G/A | 2024-02-09 | Capital International Investors | NovoCure Ltd | 8,896,076 | 8.3% | EDGAR |
| SC 13G/A | 2024-02-09 | Capital World Investors | NovoCure Ltd | 3,276,996 | 3.1% | EDGAR |
| SC 13G/A | 2023-12-11 | Capital World Investors | NovoCure Ltd | 5,834,080 | 5.5% | EDGAR |
| SC 13G/A | 2023-11-09 | BAILLIE GIFFORD & CO | NovoCure Ltd | 5,095,777 | 4.8% | EDGAR |
| SC 13G/A | 2023-02-13 | Capital World Investors | NovoCure Ltd | 12,899,395 | 12.3% | EDGAR |
| SC 13G/A | 2023-02-13 | Capital International Investors | NovoCure Ltd | 8,155,909 | 7.8% | EDGAR |
| SC 13G/A | 2023-02-09 | FMR LLC | NovoCure Ltd | 15,743,514 | 15.0% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | NovoCure Ltd | 9,547,336 | 9.1% | EDGAR |
| SC 13G/A | 2023-01-31 | BlackRock Inc. | NovoCure Ltd | 7,605,425 | 7.2% | EDGAR |
| SC 13G/A | 2023-01-23 | BAILLIE GIFFORD & CO | NovoCure Ltd | 8,863,842 | 8.4% | EDGAR |
| SC 13G/A | 2022-04-11 | FMR LLC | NovoCure Ltd | 10,736,704 | 10.3% | EDGAR |
| SC 13G/A | 2022-02-11 | Capital World Investors | NovoCure Ltd | 12,723,214 | 12.3% | EDGAR |
| SC 13G/A | 2022-02-11 | Capital International Investors | NovoCure Ltd | 11,531,075 | 11.1% | EDGAR |
| SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | NovoCure Ltd | 7,893,313 | 7.6% | EDGAR |
| SC 13G/A | 2022-02-09 | FMR LLC | NovoCure Ltd | 7,810,337 | 7.5% | EDGAR |
| SC 13G/A | 2022-02-03 | BlackRock Inc. | NovoCure Ltd | 6,689,356 | 6.4% | EDGAR |
| SC 13G/A | 2022-01-26 | BAILLIE GIFFORD & CO | NovoCure Ltd | 9,615,168 | 9.3% | EDGAR |